Kim Hyunsik, Turiano Nicholas A, Forbes Miriam K, Kotov Roman, Krueger Robert F, Eaton Nicholas R
Department of Psychology, Sogang University, Seoul, South Korea.
Department of Psychology, West Virginia University, Morgantown, WV, USA.
World Psychiatry. 2021 Jun;20(2):276-282. doi: 10.1002/wps.20859.
Previous studies have documented the utility of a transdiagnostic internalizing factor in predicting important future outcomes (e.g., subsequent mental disorder diagnoses). To date, however, no study has investigated whether an internalizing factor predicts mortality risk. Also, while pre-vious studies of mortality risk have emphasized its associations with particular internalizing disorders, no study has assessed how the transdiagnostic internalizing factor vs. disorder-specific variance differently predict that risk. The primary aims of this study were to explore: a) whether the internalizing factor predicts mortality risk, b) whether particular internalizing psychopathologies uniquely predict mortality risk over and beyond the transdiagnostic internalizing factor, and c) whether there is a significant interaction of internalizing with self-reported health in the prediction of mortality risk. We utilized a large national sample of American adults from the Midlife in the United States (MIDUS), a longitudinal study that examined midlife development of individuals across multiple waves between 1995 and 2015. Data were analyzed for the 6,329 participants who completed the phone interview and self-administered questionnaire in MIDUS 1 (1995-1996) and were then followed up until October 31, 2015 or until death. To investigate the association between internalizing and mortality risk, we used the semi-parametric proportional hazards Cox model, where survival time was regressed on a latent internalizing factor. Overall findings indicate that a transdiagnostic internalizing factor significantly predicts mortality risk over a 20-year period (hazard ratio, HR=1.12, 95% CI: 1.05-1.16, p<0.01) and that internalizing outperforms disorder-specific variance (e.g., depression-specific variance) in the prediction of that risk. Further, there was a significant interaction between transdiagnostic internalizing and self-reported health, whereby internalizing psychopathology had a specific association with early death for individuals with excellent self-reported health condition (HR=1.50, 95% CI: 1.17-1.84, p<0.05). This highlights the clinical utility of using the transdiagnostic internalizing factor for prediction of an important future outcome, and supports the argument that internalizing psychopathology can be a meaningful liability to explore in public health practice.
以往的研究已证明,一种跨诊断内化因素在预测重要的未来结果(如后续的精神障碍诊断)方面具有效用。然而,迄今为止,尚无研究调查内化因素是否能预测死亡风险。此外,虽然以往关于死亡风险的研究强调了其与特定内化障碍的关联,但尚无研究评估跨诊断内化因素与特定障碍差异如何不同地预测该风险。本研究的主要目的是探讨:a)内化因素是否能预测死亡风险;b)特定的内化精神病理学症状在跨诊断内化因素之外是否能独特地预测死亡风险;c)在内化因素与自我报告健康状况之间,在预测死亡风险时是否存在显著的交互作用。我们使用了来自美国中年(MIDUS)的大量美国成年人全国样本,这是一项纵向研究,考察了1995年至2015年期间多轮个体的中年发展情况。对在MIDUS 1(1995 - 1996)中完成电话访谈和自填问卷的6329名参与者的数据进行了分析,然后对他们进行随访,直至2015年10月31日或直至死亡。为了研究内化因素与死亡风险之间的关联,我们使用了半参数比例风险Cox模型,其中生存时间以内化潜在因素为回归变量。总体研究结果表明,一个跨诊断内化因素在20年期间显著预测死亡风险(风险比,HR = 1.12,95%置信区间:1.05 - 1.16,p < 0.01),并且在内化因素在预测该风险方面优于特定障碍差异(如抑郁症特定差异)。此外,跨诊断内化因素与自我报告健康状况之间存在显著交互作用,如果自我报告健康状况良好,内化精神病理学症状与早逝存在特定关联(HR = 1.50,95%置信区间:1.17 - 1.84,p < 0.05)。这突出了使用跨诊断内化因素预测重要未来结果的临床效用,并支持了内化精神病理学症状在公共卫生实践中是一个值得探索的有意义风险因素的观点。